Featured News
SDRC News
More News
Zinc Chelation: A siren song to draw regenerative drugs to the beta cell?
To precisely send a drug to its intended target in the body requires two things:
Dr. Karl Deisseroth has been elected to the National Academy of Engineering
Two Stanford faculty elected to the National Academy of Engineering
SDRC member Dr. Czechowicz brings hope for organ transplantation potential from any donor to any recipien
Researchers’ experimental approach for preparing mice for blood stem cell transplantation may one day make it possible in humans to safely transplant organs or cells from any donor to any recipient.
SDRC member and leader of the Clinical and Translational Core, Dr. Christopher Gardner discusses “How should we consume protein?”
Nutrition expert Christopher Gardner discusses the protein-consuming habits of America, the drawbacks and ways to eat better.
SDRC researchers use zinc to target insulin producing cells
To treat diabetes directly, rather than manage its symptoms, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.
Following events at the ADA Scientific Sessions in June, a number of concerns raised regarding the ADA's professional section remain unresolved. As a result, a boycott of ADA activities has been initiated by leading figures in diabetes research. The text below includes relevant hyperlinks with further information. Those who wish to review the petition and consider whether to sign it may do so at the links provided. This information is being shared for member awareness.